MYGN Stock Analysis: Buy, Sell, or Hold?
MYGN - Myriad Genetics Inc
$3.13
-0.08 (-2.34%)
▼
5d:
+2.46%
30d:
-44.3%
90d:
-18.19%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When MYGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MYGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MYGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: MYGN is currently trading at $3.12, which is considered slightly low relative to its 30-day fair value range of $3.02 to $5.69. From a valuation perspective, the stock is trading at a discount (Forward PE: -6.0) compared to its historical average (50.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MYGN is showing sideways momentum. Immediate support is located at $2.83, while resistance sits at $3.33.
Market Sentiment: MYGN scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.96 (+23.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MYGN is showing sideways momentum. Immediate support is located at $2.83, while resistance sits at $3.33.
Market Sentiment: MYGN scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.96 (+23.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.02 -
$5.69
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
95.2%
Protect Your Profits
Holding MYGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (92/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.6% below Wall St target ($3.96)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 43% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.02 -
$5.69
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.84
Resistance Level
$3.33
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.01
Wall Street Target
$3.96
(+23.6%)
Revenue Growth (YoY)
-20.8%
Profit Margin
-41.3%
PE vs Historical
-6.0 vs 50.8
CHEAP
Share & Embed Analysis
Last updated: August 24, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
Data refreshes hourly during market hours. Next update: 11:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYGN showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Samraat S Raha
BUY
40000 shares
2026-03-09
S. Louise Phanstiel
BUY
48000 shares
2026-02-27
S. Louise Phanstiel
BUY
50407 shares
2026-02-26
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 38 SELL |
Advanced MYGN Option Strategies
Professional options setups generated by AI based on today's MYGN price and gamma walls.
